Dianne Spillman

United States Food and Drug Administration

MedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC”.

FDA Approval Summary: Sotorasib for KRAS G12C -Mutated Metastatic NSCLC

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-3074

N/A

0.861DataRank · unranked

310 citations

Nicole Drezner, Xiaoxue Li, Pallavi S. Mishra‐Kalyani, Yajun Liu, Hong Zhao +11 more

FDA Approval Summary: Nivolumab with Ipilimumab and Chemotherapy for Metastatic Non–small Cell Lung Cancer, A Collaborative Project Orbis Review

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4338

N/A

0DataRank · unranked

57 citations

Flora Mulkey, Adnan A. Jaigirdar, Lisa Rodríguez, Yibo Wang, Yuan Xu +14 more